High income vs Japan: Cause of death, by non-communicable diseases, ages 0-4
High income
40.5%
in 2021
Japan
60.3%
in 2021
High income rank
3rd
Japan rank
1st
Cause of death, by non-communicable diseases, ages 0-4 over time
- High income
- Japan
How they compare
Japan currently reports 60.3% against 40.5% in High income, a difference of 19.8%.
That makes Japan's figure about 1.5 times High income's.
Across all 6 years both countries report, Japan has been ahead every year.
High income ranks 3rd and Japan ranks 1st of 47 groups.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | High income | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 38.9% | 55.1% | 16.2% | Japan |
| 2010s | 40.7% | 59.9% | 19.2% | Japan |
| 2020s | 40.6% | 60.1% | 19.5% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, High income or Japan?
- Japan, at 60.3% against 40.5% in High income as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between High income and Japan?
- 19.8%, with Japan ahead.
- How many years of comparable data are there for High income and Japan?
- 6 years are reported by both, from 2000 to 2021.
- How do High income and Japan rank globally for cause of death, by non-communicable diseases, ages 0-4?
- High income ranks 3rd and Japan ranks 1st of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.